Clinical efficacy of embolization via transophthalmic arterial approach for patients with anterior skull base dural arteriovenous fistulas
XU Xiu-peng
LU Hua
Abstract：Objective To investigate the clinical efficacy of embolization via transophthalmic arterial approach for patients with anterior skull base dural arteriovenous fistulas(DAVF).Methods A retrospective analysis was conducted on the clinical data of 9 patients with anterior skull base DAVF who underwent embolization via transophthalmic arterial approach from April 2017 to May 2022.Results Four patients presented with frontal lobe hematoma with subarachnoid hemorrhage,2 with headache,1 with conjunctival edema and 2 without any symptoms.Two patients were classified as Cognard type Ⅲ and 7 as type Ⅳ.Onyx-18 glue was used in all 9 patients,and immediate postoperative angiography showed complete embolization without surgical complications.The average follow-up was(11.8±1.33)months,ranging from 6 to 18 months.At the last follow-up,all symptoms disappeared without recurrence in all patients.Conclusions Embolization via transophthalmic arterial approach is clinically safe and feasible for patients with anterior skull base DAVF,with short-term and mid-term good efficacy.
Keywords：Anterior skull base dural arteriovenous fistulasEndovascular embolizationTransophthalmic arterial approachOnyx-18 glueClinical efficacy
Publication Date：2023-12-25
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 678-680,684 )